{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T06:38:46Z","timestamp":1782283126247,"version":"3.54.5"},"reference-count":125,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,2,5]],"date-time":"2021-02-05T00:00:00Z","timestamp":1612483200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["137183, 151486"],"award-info":[{"award-number":["137183, 151486"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Common variable immunodeficiency (CVID) is the most frequently diagnosed primary antibody deficiency. About half of CVID patients develop chronic non-infectious complications thought to be due to intrinsic immune dysregulation, including autoimmunity, gastrointestinal disease, and interstitial lung disease (ILD). Multiple studies have found ILD to be a significant cause of morbidity and mortality in CVID. Yet, the precise mechanisms underlying this complication in CVID are poorly understood. CVID ILD is marked by profound pulmonary infiltration of both T and B cells as well as granulomatous inflammation in many cases. B cell depletive therapy, whether done as a monotherapy or in combination with another immunosuppressive agent, has become a standard of therapy for CVID ILD. However, CVID is a heterogeneous disorder, as is its lung pathology, and the precise patients that would benefit from B cell depletive therapy, when it should administered, and how long it should be repeated all remain gaps in our knowledge. Moreover, some have ILD recurrence after B cell depletive therapy and the relative importance of B cell biology remains incompletely defined. Developmental and functional abnormalities of B cell compartments observed in CVID ILD and related conditions suggest that imbalance of B cell signaling networks may promote lung disease. Included within these potential mechanisms of disease is B cell activating factor (BAFF), a cytokine that is upregulated by the interferon gamma (IFN-\u03b3):STAT1 signaling axis to potently influence B cell activation and survival. B cell responses to BAFF are shaped by the divergent effects and expression patterns of its three receptors: BAFF receptor (BAFF-R), transmembrane activator and CAML interactor (TACI), and B cell maturation antigen (BCMA). Moreover, soluble forms of BAFF-R, TACI, and BCMA exist and may further influence the pathogenesis of ILD. Continued efforts to understand how dysregulated B cell biology promotes ILD development and progression will help close the gap in our understanding of how to best diagnose, define, and manage ILD in CVID.<\/jats:p>","DOI":"10.3389\/fimmu.2020.622114","type":"journal-article","created":{"date-parts":[[2021,2,5]],"date-time":"2021-02-05T08:09:47Z","timestamp":1612512587000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":28,"title":["B Cell Dysregulation in Common Variable Immunodeficiency Interstitial Lung Disease"],"prefix":"10.3389","volume":"11","author":[{"given":"Erik M.","family":"Matson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miranda L.","family":"Abyazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kayla A.","family":"Bell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin M.","family":"Hayes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul J.","family":"Maglione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,2,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2016.08.005","article-title":"Lung Disease in Primary Antibody Deficiencies","volume":"4","author":"Schussler","year":"2016","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B2","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1146\/annurev.immunol.021908.132649","article-title":"Primary B cell immunodeficiencies: comparisons and contrasts","volume":"27","author":"Conley","year":"2009","journal-title":"Annu Rev Immunol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2010.08077.x","article-title":"Update on the hyper immunoglobulin M syndromes","volume":"149","author":"Davies","year":"2010","journal-title":"Br J Haematol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1016\/j.jaci.2012.03.025","article-title":"Common variable immunodeficiency","volume":"129","author":"Cunningham-Rundles","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019002062","article-title":"Common variable immune deficiency: case studies","volume":"134","author":"Cunningham-Rundles","year":"2019","journal-title":"Blood"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1111\/imr.12728","article-title":"Common variable immune deficiency: Dissection of the variable","volume":"287","author":"Cunningham-Rundles","year":"2019","journal-title":"Immunol Rev"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-019-00640-5","article-title":"Factors Beyond Lack of Antibody Govern Pulmonary Complications in Primary Antibody Deficiency","volume":"39","author":"Weinberger","year":"2019","journal-title":"J Clin Immunol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtauto.2019.100025","article-title":"The clinical implications of selective IgA deficiency","volume":"2","author":"Swain","year":"2019","journal-title":"J Transl Autoimmun"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-11-124545","article-title":"Common variable immunodeficiency disorders: division into distinct clinical phenotypes","volume":"112","author":"Chapel","year":"2008","journal-title":"Blood"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-09-377945","article-title":"Morbidity and mortality in common variable immune deficiency over 4 decades","volume":"119","author":"Resnick","year":"2012","journal-title":"Blood"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01837","article-title":"The Lung in Primary Immunodeficiencies: New Concepts in Infection and Inflammation","volume":"9","author":"Baumann","year":"2018","journal-title":"Front Immunol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2004.05.057","article-title":"Granulomatous-lymphocytic lung disease shortens survival in common variable immunodeficiency","volume":"114","author":"Bates","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.iac.2020.03.003","article-title":"Chronic Lung Disease in Primary Antibody Deficiency: Diagnosis and Management","volume":"40","author":"Maglione","year":"2020","journal-title":"Immunol Allergy Clin North Am"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.anai.2014.04.024","article-title":"Pulmonary radiologic findings in common variable immunodeficiency: clinical and immunological correlations","volume":"113","author":"Maglione","year":"2014","journal-title":"Ann Allergy Asthma Immunol"},{"key":"B15","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2020.07.021","article-title":"Rituximab and antimetabolite treatment of granulomatous and lymphocytic interstitial lung disease in common variable immunodeficiency","volume-title":"J Allergy Clin Immunol","author":"Verbsky","year":"2020"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2014.523","article-title":"Use of azathioprine for graft-vs-host disease is the major risk for development of secondary malignancies after haematopoietic stem cell transplantation: a nationwide population-based study","volume":"112","author":"Chien","year":"2015","journal-title":"Br J Cancer"},{"key":"B17","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s11882-016-0597-6","article-title":"Autoimmune and Lymphoproliferative Complications of Common Variable Immunodeficiency","volume":"16","author":"Maglione","year":"2016","journal-title":"Curr Allergy Asthma Rep"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02753","article-title":"Current Understanding and Recent Developments in Common Variable Immunodeficiency Associated Autoimmunity","volume":"10","author":"Gereige","year":"2019","journal-title":"Front Immunol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/ni.2771","article-title":"Dominant-activating germline mutations in the gene encoding the PI(3)K catalytic subunit p110\u03b4 result in T cell senescence and human immunodeficiency","volume":"15","author":"Lucas","year":"2014","journal-title":"Nat Immunol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-08-801191","article-title":"Effective \u201cactivated PI3K\u03b4 syndrome\u201d-targeted therapy with the PI3K\u03b4 inhibitor leniolisib","volume":"130","author":"Rao","year":"2017","journal-title":"Blood"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaa1663","article-title":"AUTOIMMUNE DISEASE. Patients with LRBA deficiency show CTLA4 loss and immune dysregulation responsive to abatacept therapy","volume":"349","author":"Lo","year":"2015","journal-title":"Science"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2018.02.055","article-title":"Phenotype, penetrance, and treatment of 133 cytotoxic T-lymphocyte antigen 4-insufficient subjects","volume":"142","author":"Schwab","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2013.08.022","article-title":"Tertiary lymphoid neogenesis is a component of pulmonary lymphoid hyperplasia in patients with common variable immunodeficiency","volume":"133","author":"Maglione","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1007\/s10875-012-9778-9","article-title":"Granulomatous disease in CVID: retrospective analysis of clinical characteristics and treatment efficacy in a cohort of 59 patients","volume":"33","author":"Boursiquot","year":"2013","journal-title":"J Clin Immunol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-012-9755-3","article-title":"Use of combination chemotherapy for treatment of granulomatous and lymphocytic interstitial lung disease (GLILD) in patients with common variable immunodeficiency (CVID)","volume":"33","author":"Chase","year":"2013","journal-title":"J Clin Immunol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1111\/cei.12856","article-title":"FDG PET-CT imaging of therapeutic response in granulomatous lymphocytic interstitial lung disease (GLILD) in common variable immunodeficiency (CVID)","volume":"187","author":"Jolles","year":"2017","journal-title":"Clin Exp Immunol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2018.01559","article-title":"Lymphoid Interstitial Pneumonia in Common Variable Immune Deficiency - Case Report With Disease Monitoring in Various Therapeutic Options: Pleiotropic Effects of Rituximab Regimens","volume":"9","author":"Zdziarski","year":"2018","journal-title":"Front Pharmacol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.122728","article-title":"BAFF-driven B cell hyperplasia underlies lung disease in common variable immunodeficiency","volume":"4","author":"Maglione","year":"2019","journal-title":"JCI Insight"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1111\/cei.13343","article-title":"Interstitial lung disease in patients with common variable immunodeficiency disorders: several different pathologies","volume":"198","author":"Patel","year":"2019","journal-title":"Clin Exp Immunol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1053\/j.sult.2013.05.002","article-title":"Lymphoproliferative lung disorders: a radiologic-pathologic overview. Part I: Reactive disorders","volume":"34","author":"Carrillo","year":"2013","journal-title":"Semin Ultrasound CT MR"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2007.04.012","article-title":"High serum levels of BAFF, APRIL, and TACI in common variable immunodeficiency","volume":"124","author":"Knight","year":"2007","journal-title":"Clin Immunol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3892\/ijmm.21.2.233","article-title":"Age-related changes in BAFF and APRIL profiles and upregulation of BAFF and APRIL expression in patients with primary antibody deficiency","volume":"21","author":"Jin","year":"2008","journal-title":"Int J Mol Med"},{"key":"B33","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1182\/blood.V97.1.198","article-title":"Synthesis and release of B-lymphocyte stimulator from myeloid cells","volume":"97","author":"Nardelli","year":"2001","journal-title":"Blood"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1084\/jem.189.11.1747","article-title":"BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth","volume":"189","author":"Schneider","year":"1999","journal-title":"J Exp Med"},{"key":"B35","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1038\/nri2572","article-title":"Cracking the BAFF code","volume":"9","author":"Mackay","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M306852200","article-title":"DeltaBAFF, an alternate splice isoform that regulates receptor binding and biopresentation of the B cell survival cytokine, BAFF","volume":"278","author":"Gavin","year":"2003","journal-title":"J Biol Chem"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.cytogfr.2013.04.003","article-title":"The BAFF\/APRIL system: emerging functions beyond B cell biology and autoimmunity","volume":"24","author":"Vincent","year":"2013","journal-title":"Cytokine Growth Factor Rev"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.179.11.7276","article-title":"Regulated expression of BAFF-binding receptors during human B cell differentiation","volume":"179","author":"Darce","year":"2007","journal-title":"J Immunol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1128\/CMR.00046-17","article-title":"The Role of BAFF System Molecules in Host Response to Pathogens","volume":"30","author":"Sakai","year":"2017","journal-title":"Clin Microbiol Rev"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-05-575845","article-title":"Differential induction of plasma cells by isoforms of human TACI","volume":"125","author":"Garcia-Carmona","year":"2015","journal-title":"Blood"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2013.01.046","article-title":"B-cell biology and development","volume":"131","author":"Pieper","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2015.03.005","article-title":"BAFF receptors and ligands create independent homeostatic niches for B cell subsets","volume":"34","author":"Naradikian","year":"2015","journal-title":"Curr Opin Immunol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1615\/CritRevImmunol.v32.i4.10","article-title":"Regulatory roles of the tumor necrosis factor receptor BCMA","volume":"32","author":"Coquery","year":"2012","journal-title":"Crit Rev Immunol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2013.00509","article-title":"Non-Canonical NF-\u03baB Signaling Initiated by BAFF Influences B Cell Biology at Multiple Junctures","volume":"4","author":"Gardam","year":"2014","journal-title":"Front Immunol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2014.02.004","article-title":"Role of BAFF\/BAFF-R axis in B-cell non-Hodgkin lymphoma","volume":"91","author":"Yang","year":"2014","journal-title":"Crit Rev Oncol Hematol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-06-027755","article-title":"BAFF and APRIL support chronic lymphocytic leukemia B-cell survival through activation of the canonical NF-kappaB pathway","volume":"109","author":"Endo","year":"2007","journal-title":"Blood"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2019.00594","article-title":"BAFF\/APRIL System Is Functional in B-Cell Acute Lymphoblastic Leukemia in a Disease Subtype Manner","volume":"9","author":"Sevdali","year":"2019","journal-title":"Front Oncol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-013-1545-4","article-title":"NF-\u03baB pathways in hematological malignancies","volume":"71","author":"Gasparini","year":"2014","journal-title":"Cell Mol Life Sci"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1126\/science.1062677","article-title":"Activation by IKKalpha of a second, evolutionary conserved, NF-kappa B signaling pathway","volume":"293","author":"Senftleben","year":"2001","journal-title":"Science"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/S1097-2765(01)00187-3","article-title":"NF-kappaB-inducing kinase regulates the processing of NF-kappaB2 p100","volume":"7","author":"Xiao","year":"2001","journal-title":"Mol Cell"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1038\/ni.1678","article-title":"Nonredundant and complementary functions of TRAF2 and TRAF3 in a ubiquitination cascade that activates NIK-dependent alternative NF-kappaB signaling","volume":"9","author":"Vallabhapurapu","year":"2008","journal-title":"Nat Immunol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1038\/ni.1676","article-title":"Noncanonical NF-kappaB activation requires coordinated assembly of a regulatory complex of the adaptors cIAP1, cIAP2, TRAF2 and TRAF3 and the kinase NIK","volume":"9","author":"Zarnegar","year":"2008","journal-title":"Nat Immunol"},{"key":"B53","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1111\/j.1600-065X.2010.00942.x","article-title":"In vivo control of B-cell survival and antigen-specific B-cell responses","volume":"237","author":"Chan","year":"2010","journal-title":"Immunol Rev"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1038\/ni842","article-title":"BAFF-induced NEMO-independent processing of NF-kappa B2 in maturing B cells","volume":"3","author":"Claudio","year":"2002","journal-title":"Nat Immunol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2013.00477","article-title":"A Complex Relationship between TRAF3 and Non-Canonical NF-\u03baB2 Activation in B Lymphocytes","volume":"4","author":"Lin","year":"2013","journal-title":"Front Immunol"},{"key":"B56","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.immuni.2008.01.009","article-title":"TRAF2 and TRAF3 signal adapters act cooperatively to control the maturation and survival signals delivered to B cells by the BAFF receptor","volume":"28","author":"Gardam","year":"2008","journal-title":"Immunity"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20100857","article-title":"and reveals new insights into BAFF-R signaling","volume":"207","author":"Hildebrand","year":"2010","journal-title":"J Exp Med"},{"key":"B58","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1750-2187-8-7","article-title":"TRAF molecules in cell signaling and in human diseases","volume":"8","author":"Xie","year":"2013","journal-title":"J Mol Signal"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2013.10.022","article-title":"Context-specific BAFF-R signaling by the NF-\u03baB and PI3K pathways","volume":"5","author":"Jellusova","year":"2013","journal-title":"Cell Rep"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1021\/bi048227k","article-title":"Selectivity of BAFF\/BLyS and APRIL for binding to the TNF family receptors BAFFR\/BR3 and BCMA","volume":"44","author":"Day","year":"2005","journal-title":"Biochemistry"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M411714200","article-title":"Structures of APRIL-receptor complexes: like BCMA, TACI employs only a single cysteine-rich domain for high affinity ligand binding","volume":"280","author":"Hymowitz","year":"2005","journal-title":"J Biol Chem"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-09-110874","article-title":"TACI, unlike BAFF-R, is solely activated by oligomeric BAFF and APRIL to support survival of activated B cells and plasmablasts","volume":"111","author":"Bossen","year":"2008","journal-title":"Blood"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-08-2694","article-title":"BAFF\/BLyS can potentiate B-cell selection with the B-cell coreceptor complex","volume":"103","author":"Hase","year":"2004","journal-title":"Blood"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1038\/ni.1914","article-title":"The transmembrane activator TACI triggers immunoglobulin class switching by activating B cells through the adaptor MyD88","volume":"11","author":"He","year":"2010","journal-title":"Nat Immunol"},{"key":"B65","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1038\/s41467-017-01602-4","article-title":"mTOR intersects antibody-inducing signals from TACI in marginal zone B cells","volume":"8","author":"Sintes","year":"2017","journal-title":"Nat Commun"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1002\/eji.200636623","article-title":"TACI attenuates antibody production costimulated by BAFF-R and CD40","volume":"37","author":"Sakurai","year":"2007","journal-title":"Eur J Immunol"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1126\/science.278.5335.138","article-title":"NF-AT activation induced by a CAML-interacting member of the tumor necrosis factor receptor superfamily","volume":"278","author":"von B\u00fclow","year":"1997","journal-title":"Science"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-05-575845","article-title":"Differential induction of plasma cells by isoforms of human TACI","volume":"125","author":"Garcia-Carmona","year":"2015","journal-title":"Blood"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02125","article-title":"TACI Isoforms Regulate Ligand Binding and Receptor Function","volume":"9","author":"Garcia-Carmona","year":"2018","journal-title":"Front Immunol"},{"key":"B70","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.immuni.2007.05.019","article-title":"Transcription factor Pax5 activates the chromatin of key genes involved in B cell signaling, adhesion, migration, and immune function","volume":"27","author":"Schebesta","year":"2007","journal-title":"Immunity"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1309\/3WG32YRAMQ7RB9D4","article-title":"Lineage determination of CD20- B-Cell neoplasms: an immunohistochemical study","volume":"126","author":"Chu","year":"2006","journal-title":"Am J Clin Pathol"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.22034\/APJCP.2018.19.2.331","article-title":"Cd20 Expression and Effects on Outcome of Relapsed\/ Refractory Diffuse Large B Cell Lymphoma after Treatment with Rituximab","volume":"19","author":"Rasheed","year":"2018","journal-title":"Asian Pac J Cancer Prev"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1309\/UXLE9RHL968TER7B","article-title":"Rituximab-induced changes in hematolymphoid tissues found at autopsy","volume":"130","author":"Cioc","year":"2008","journal-title":"Am J Clin Pathol"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.3121\/cmr.2010.891","article-title":"PAX-5: a valuable immunohistochemical marker in the differential diagnosis of lymphoid neoplasms","volume":"8","author":"Desouki","year":"2010","journal-title":"Clin Med Res"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1038\/ng1600","article-title":"Mutations in TNFRSF13B encoding TACI are associated with common variable immunodeficiency in humans","volume":"37","author":"Salzer","year":"2005","journal-title":"Nat Genet"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1038\/ng1601","article-title":"TACI is mutant in common variable immunodeficiency and IgA deficiency","volume":"37","author":"Castigli","year":"2005","journal-title":"Nat Genet"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2007.10.001","article-title":"Transmembrane activator and calcium-modulating cyclophilin ligand interactor mutations in common variable immunodeficiency: clinical and immunologic outcomes in heterozygotes","volume":"120","author":"Zhang","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1600017","article-title":"Cutting Edge: BAFF Promotes Autoantibody Production via TACI-Dependent Activation of Transitional B Cells","volume":"196","author":"Jacobs","year":"2016","journal-title":"J Immunol"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2011.01.048","article-title":"Functional analysis of transmembrane activator and calcium-modulating cyclophilin ligand interactor (TACI) mutations associated with common variable immunodeficiency","volume":"128","author":"Fried","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1038\/gene.2009.43","article-title":"An evolutionary approach to the medical implications of the tumor necrosis factor receptor superfamily member 13B (TNFRSF13B) gene","volume":"10","author":"Sazzini","year":"2009","journal-title":"Genes Immun"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/8390356","article-title":"Clinical Associations of Biallelic and Monoallelic TNFRSF13B Variants in Italian Primary Antibody Deficiency Syndromes","volume":"2016","author":"Pulvirenti","year":"2016","journal-title":"J Immunol Res"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201242945","article-title":"Naturally occurring mutation affecting the MyD88-binding site of TNFRSF13B impairs triggering of class switch recombination","volume":"43","author":"Almejun","year":"2013","journal-title":"Eur J Immunol"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0903543106","article-title":"B-cell activating factor receptor deficiency is associated with an adult-onset antibody deficiency syndrome in humans","volume":"106","author":"Warnatz","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2013.11.021","article-title":"A common single nucleotide polymorphism impairs B-cell activating factor receptor\u2019s multimerization, contributing to common variable immunodeficiency","volume":"133","author":"Pieper","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"B85","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1007\/s10875-005-5637-2","article-title":"Mutational analysis of human BAFF receptor TNFRSF13C (BAFF-R) in patients with common variable immunodeficiency","volume":"25","author":"Losi","year":"2005","journal-title":"J Clin Immunol"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2018.07.002","article-title":"Shedding of BAFF\/APRIL Receptors Controls B Cells","volume":"39","author":"Meinl","year":"2018","journal-title":"Trends Immunol"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2017.02.005","article-title":"BAFF- and TACI-Dependent Processing of BAFFR by ADAM Proteases Regulates the Survival of B Cells","volume":"18","author":"Smulski","year":"2017","journal-title":"Cell Rep"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1402070","article-title":"The immunoregulator soluble TACI is released by ADAM10 and reflects B cell activation in autoimmunity","volume":"194","author":"Hoffmann","year":"2015","journal-title":"J Immunol"},{"key":"B89","doi-asserted-by":"publisher","first-page":"7333","DOI":"10.1038\/ncomms8333","article-title":"\u03b3-Secretase directly sheds the survival receptor BCMA from plasma cells","volume":"6","author":"Laurent","year":"2015","journal-title":"Nat Commun"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1038\/icb.2009.75","article-title":"Reverse signaling through BAFF differentially regulates the expression of inflammatory mediators and cytoskeletal movements in THP-1 cells","volume":"88","author":"Jeon","year":"2010","journal-title":"Immunol Cell Biol"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0061350","article-title":"No evidence that soluble TACI induces signalling via membrane-expressed BAFF and APRIL in myeloid cells","volume":"8","author":"Nys","year":"2013","journal-title":"PloS One"},{"key":"B92","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.jaip.2019.08.012","article-title":"Serum B-Cell Maturation Antigen (BCMA) Levels Differentiate Primary Antibody Deficiencies","volume":"8","author":"Maglione","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1111\/cei.12915","article-title":"When to initiate immunoglobulin replacement therapy (IGRT) in antibody deficiency: a practical approach","volume":"188","author":"Jolles","year":"2017","journal-title":"Clin Exp Immunol"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1001\/jama.281.3.243","article-title":"Safety of revaccination with pneumococcal polysaccharide vaccine","volume":"281","author":"Jackson","year":"1999","journal-title":"Jama"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/key394","article-title":"Recommendations for the management of secondary hypogammaglobulinaemia due to B cell targeted therapies in autoimmune rheumatic diseases","volume":"58","author":"Wijetilleka","year":"2019","journal-title":"Rheumatol (Oxford)"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2015.07.004","article-title":"Progression of Common Variable Immunodeficiency Interstitial Lung Disease Accompanies Distinct Pulmonary and Laboratory Findings","volume":"3","author":"Maglione","year":"2015","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1038\/ni829","article-title":"DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL","volume":"3","author":"Litinskiy","year":"2002","journal-title":"Nat Immunol"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0074893","article-title":"Interferon signature in the blood in inflammatory common variable immune\u00a0deficiency","volume":"8","author":"Park","year":"2013","journal-title":"PloS One"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.164.1.488","article-title":"Up-regulation of IL-12 in monocytes: a fundamental defect in common variable immunodeficiency","volume":"164","author":"Cambronero","year":"2000","journal-title":"J Immunol"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.2006.03063.x","article-title":"Elevated serum interleukin (IL)-12p40 levels in common variable immunodeficiency disease and decreased peripheral blood dendritic cells: analysis of IL-12p40 and interferon-gamma gene","volume":"144","author":"Martinez-Pomar","year":"2006","journal-title":"Clin Exp Immunol"},{"key":"B101","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1016\/j.jaci.2015.09.013","article-title":"Expansion of inflammatory innate lymphoid cells in patients with common variable immune deficiency","volume":"137","author":"Cols","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.00174","article-title":"Follicular T Cells from smB(-) Common Variable Immunodeficiency Patients Are Skewed Toward a Th1 Phenotype","volume":"8","author":"Cunill","year":"2017","journal-title":"Front Immunol"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2017.04.041","article-title":"The T(H)1 phenotype of follicular helper T cells indicates an IFN-\u03b3-associated immune dysregulation in patients with CD21low common variable immunodeficiency","volume":"141","author":"Unger","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2018.09.006","article-title":"Increase of follicular helper T cells skewed toward a Th1 profile in CVID patients with non-infectious clinical complications","volume":"197","author":"Turpin","year":"2018","journal-title":"Clin Immunol"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2020.01.046","article-title":"Plasma protein profiling reflects T(H)1-driven immune dysregulation in common variable immunodeficiency","volume":"146","author":"Hultberg","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1172\/JCI69854","article-title":"CVID-associated TACI mutations affect autoreactive B cell selection and activation","volume":"123","author":"Romberg","year":"2013","journal-title":"J Clin Invest"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2004.05.010","article-title":"Excess BAFF rescues self-reactive B cells from peripheral deletion and allows them to enter forbidden follicular and marginal zone niches","volume":"20","author":"Thien","year":"2004","journal-title":"Immunity"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1016\/S1074-7613(04)00079-2","article-title":"Reduced competitiveness of autoantigen-engaged B cells due to increased dependence on BAFF","volume":"20","author":"Lesley","year":"2004","journal-title":"Immunity"},{"key":"B109","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1182\/blood-2007-06-091744","article-title":"The EUROclass trial: defining subgroups in common variable immunodeficiency","volume":"111","author":"Wehr","year":"2008","journal-title":"Blood"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2004.10.048","article-title":"The loss of IgM memory B cells correlates with clinical disease in common variable immunodeficiency","volume":"115","author":"Carsetti","year":"2005","journal-title":"J Allergy Clin Immunol"},{"key":"B111","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.cellsig.2018.09.012","article-title":"BAFF inhibits autophagy promoting cell proliferation and survival by activating Ca(2+)-CaMKII-dependent Akt\/mTOR signaling pathway in normal and neoplastic B-lymphoid cells","volume":"53","author":"Dong","year":"2019","journal-title":"Cell Signal"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.576724","article-title":"Immune Monitoring of Patients With Primary Immune Regulation Disorders Unravels Higher Frequencies of Follicular T Cells With Different Profiles That Associate With Alterations in B Cell Subsets","volume":"11","author":"Caldirola","year":"2020","journal-title":"Front Immunol"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20080238","article-title":"Constitutive CD40 signaling in B cells selectively activates the noncanonical NF-kappaB pathway and promotes lymphomagenesis","volume":"205","author":"H\u00f6mig-H\u00f6lzel","year":"2008","journal-title":"J Exp Med"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2013.00376","article-title":"CD40-Mediated Activation of the NF-\u03baB2 Pathway","volume":"4","author":"Hostager","year":"2013","journal-title":"Front Immunol"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0011-2016","article-title":"Pulmonary manifestations of Sj\u00f6gren\u2019s syndrome","volume":"25","author":"Flament","year":"2016","journal-title":"Eur Respir Rev"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1002\/art.22458","article-title":"Aberrant expression of BAFF by B lymphocytes infiltrating the salivary glands of patients with primary Sj\u00f6gren\u2019s syndrome","volume":"56","author":"Daridon","year":"2007","journal-title":"Arthritis Rheum"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1002\/art.21205","article-title":"Is periodontal disease mediated by salivary BAFF in Sj\u00f6gren\u2019s syndrome","volume":"52","author":"Pers","year":"2005","journal-title":"Arthritis Rheum"},{"key":"B118","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1172\/JCI0214121","article-title":"Association of BAFF\/BLyS overexpression and altered B cell differentiation with Sj\u00f6gren\u2019s syndrome","volume":"109","author":"Groom","year":"2002","journal-title":"J Clin Invest"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1136\/ard.62.2.168","article-title":"The level of BLyS (BAFF) correlates with the titre of autoantibodies in human Sj\u00f6gren\u2019s syndrome","volume":"62","author":"Mariette","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2012-201381","article-title":"Prevalence of interferon type I signature in CD14 monocytes of patients with Sjogren\u2019s syndrome and association with disease activity and BAFF gene expression","volume":"72","author":"Brkic","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"B121","doi-asserted-by":"publisher","first-page":"16912","DOI":"10.1038\/s41598-017-17208-1","article-title":"Association between nonspecific interstitial pneumonia and presence of CD20+\u2009B lymphocytes within pulmonary lymphoid follicles","volume":"7","author":"Peng","year":"2017","journal-title":"Sci Rep"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)61303-9","article-title":"Chronic obstructive pulmonary disease in non-smokers","volume":"374","author":"Salvi","year":"2009","journal-title":"Lancet"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa032158","article-title":"The nature of small-airway obstruction in chronic obstructive pulmonary disease","volume":"350","author":"Hogg","year":"2004","journal-title":"N Engl J Med"},{"key":"B124","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1164\/rccm.201501-0107OC","article-title":"An Orchestrator of Lymphoid Follicles in Severe Chronic Obstructive Pulmonary Disease","volume":"192","author":"Polverino","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201501-0103OC","article-title":"Role of B Cell-Activating Factor in Chronic Obstructive Pulmonary Disease","volume":"192","author":"Seys","year":"2015","journal-title":"Am J Respir Crit Care Med"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2020.622114\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,5]],"date-time":"2021-02-05T08:09:50Z","timestamp":1612512590000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2020.622114\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,5]]},"references-count":125,"alternative-id":["10.3389\/fimmu.2020.622114"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2020.622114","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,5]]},"article-number":"622114"}}